Allpennystocks.com Featured Company: Millennium Biotechnologies Inc. (MBTG.OB) Reports 40% Sales Growth in Greek Market
Millennium Biotechnologies has reported 2007 sales figures of their Resurgex line of products in Greece. They finished their year with $50,000 in sales, 40% higher than their 2006 revenues of $30,000. Their successful entry into a tough market like the one in Greece is largely attributed to their relationship with Nutrimedica. Nutrimedica is a distributor that has preexisting knowledge of Greek regulations, markets and consumers that has allowed Millennium Biotechnolgies to gain access to the right place at the right time. Resurgex is marketed with three products, Resurgex, Resurgex Plus and Resurgex Select. All three are designed to help cancer…